Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6171684de68ce62ef3fbf1655618249 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4725 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N31-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89f5ae2d750204145e89a68b999f32f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f3cf2e0af6d02eab0b5f1d1c510f4f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8deea970659a89f7d98a5be1e4811aa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6fc55e4d6f909486fc21f42c28ad142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39ae097d843fcc7374169b249f02421d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b2ce9b5921d77cde2c62a1dfc21dca7 |
publicationDate |
2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20140148346-A |
titleOfInvention |
Biomarkers for diagnosing rheumatoid arthritis |
abstract |
The present invention relates to a pharmaceutical composition comprising an agent for measuring the expression level of at least one protein selected from the group consisting of sCD14 (soluble CD14), a-1-acid glycoprotein 1 and AGP2 (a-1-acid glycoprotein 2) To a diagnostic composition for rheumatoid arthritis. The present invention also relates to a method for providing information for diagnosis of kits, protein chips and rheumatoid arthritis using the composition. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020256351-A1 |
priorityDate |
2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |